Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran-Reference-Cited by-同舟云学术

Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran

Published:2020-02-03 Issue:2 Volume:32 Page:75-82
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Haratiasl Ahad Ali¹,Hamzelou Gholamreza²,Amini Sirus²,Kardan-Yamchi Jalil³,Haeili Mehri⁴,Heidari Fereshteh¹,Feizabadi Mohammad Mehdi¹⁵

Affiliation:

1. Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran;

2. Department of Health, Tehran Regional Reference Laboratory for Tuberculosis, Tehran University of Medical Sciences, Tehran, Iran;

3. Division of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran;

4. Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran;

5. Thoracic Research Center, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2020.1716479

Reference33 articles.

1. THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.

2. Global Trends in Resistance to Antituberculosis Drugs

3. Prevalence of drug-resistant tuberculosis in Iran: Systematic review and meta-analysis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards the development of better therapeutic agents for Mycobacterium Tuberculosis: Computational design and evaluation of pyrazinone derivatives as inhibitors of enoyl acyl carrier protein reductase;2024-07-18

2. Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran: Systematic review and meta-analysis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-05

3. Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy;Microbiology Spectrum;2024-04-02

4. Towards the Development of Better Therapeutic Agents for Mycobacterium Tuberculosis: Computational Design and Evaluation of Pyrazinone Derivatives as Inhibitors of Enoyl Acyl Carrier Protein Reductase;2024

5. Establishment and evaluation of an overlap extension polymerase chain reaction technique for rapid and efficient detection of drug-resistance in Mycobacterium tuberculosis;Infectious Diseases of Poverty;2022-03-24